{"id":14101,"date":"2021-04-24T15:57:52","date_gmt":"2021-04-24T13:57:52","guid":{"rendered":"https:\/\/popelky.cz\/pokus_sablona\/?p=14101"},"modified":"2023-07-20T15:09:26","modified_gmt":"2023-07-20T13:09:26","slug":"uhrada-vakciny-proti-meningokokokum-skupiny-b-zafungovala-behem-roku-vyrazne-stoupla-proockovanost-nejohrozenejsich-deti","status":"publish","type":"post","link":"https:\/\/popelky.cz\/verze7-0\/rodina-a-drobotina\/uhrada-vakciny-proti-meningokokokum-skupiny-b-zafungovala-behem-roku-vyrazne-stoupla-proockovanost-nejohrozenejsich-deti.html","title":{"rendered":"\u00dahrada vakc\u00edny proti meningokokok\u016fm skupiny B zafungovala. B\u011bhem roku v\u00fdrazn\u011b stoupla proo\u010dkovanost nejohro\u017een\u011bj\u0161\u00edch d\u011bt\u00ed"},"content":{"rendered":"

Views: 53<\/p>

Zhruba 2,5kr\u00e1t se za posledn\u00ed rok zv\u00fd\u0161ila proo\u010dkovanost nejmen\u0161\u00edch d\u011bt\u00ed proti onemocn\u011bn\u00edm zp\u016fsoben\u00fdmi meningokoky skupiny B. Za n\u00e1r\u016fstem z\u00e1jmu stoj\u00ed mimo jin\u00e9 i pln\u00e1 \u00fahrada vakc\u00edny, kter\u00e1 plat\u00ed p\u0159i zah\u00e1jen\u00ed o\u010dkov\u00e1n\u00ed do konce 6. m\u011bs\u00edce v\u011bku d\u00edt\u011bte. Podle odhadu l\u00e9ka\u0159\u016f by se letos d\u00edky tomu mohla proo\u010dkovanost kojenc\u016f dostat t\u00e9m\u011b\u0159 k 70 procent\u016fm.<\/p>\n

V\u00fdrazn\u00e9 zv\u00fd\u0161en\u00ed z\u00e1jmu o o\u010dkov\u00e1n\u00ed potvrzuj\u00ed data poskytnut\u00e1 pediatry. Zat\u00edmco je\u0161t\u011b v roce 2019 nao\u010dkoval d\u011btsk\u00fd l\u00e9ka\u0159 proti invazivn\u00edm meningokokov\u00fdm onemocn\u011bn\u00edm (IMO) skupiny B v pr\u016fm\u011bru jen 19 d\u011bt\u00ed ro\u010dn\u011b, loni se tato hodnota vy\u0161plhala na 54 nao\u010dkovan\u00fdch kojenc\u016f.1<\/sup> Nao\u010dkov\u00e1no tedy bylo 2,5kr\u00e1t v\u00edce d\u011bt\u00ed ne\u017e v roce p\u0159ede\u0161l\u00e9m. Nejvy\u0161\u0161\u00ed n\u00e1r\u016fst z\u00e1jmu pediat\u0159i eviduj\u00ed pr\u00e1v\u011b u d\u011bt\u00ed ve v\u011bkov\u00e9 kategorii\u00a0 2-6 m\u011bs\u00edc\u016f (n\u00e1r\u016fst o 58 %), kter\u00fdm vakc\u00ednu pln\u011b hrad\u00ed zdravotn\u00ed poji\u0161\u0165ovny. V\u011bk d\u011bt\u00ed o\u010dkovan\u00fdch proti meningokok\u016fm skupiny B se d\u00edky tomu v\u00fdrazn\u011b posunul pr\u00e1v\u011b do nejohro\u017een\u011bj\u0161\u00ed kategorie.<\/p>\n

Do pln\u00e9 \u00fahrady vstoupila vakc\u00edna Bexsero proti meningokok\u016fm skupiny B po novele z\u00e1kona \u010d. 48\/1997 Sb., o ve\u0159ejn\u00e9m zdravotn\u00edm poji\u0161t\u011bn\u00ed a o zm\u011bn\u011b a dopln\u011bn\u00ed n\u011bkter\u00fdch souvisej\u00edc\u00edch z\u00e1kon\u016f, 1. kv\u011btna lo\u0148sk\u00e9ho roku. \u010cesk\u00e1 republika se tehdy stala teprve sedmou zem\u00ed na sv\u011bt\u011b, kter\u00e1 za\u010dala tento typ o\u010dkov\u00e1n\u00ed nejohro\u017een\u011bj\u0161\u00ed skupin\u011b d\u011bt\u00ed pln\u011b hradit. Prvn\u00ed v\u00fdro\u010d\u00ed \u00fahrady tohoto o\u010dkov\u00e1n\u00ed navazuje na dal\u0161\u00ed v\u00fdznamn\u00e9 datum, kter\u00fdm je Sv\u011btov\u00fd den menigitidy p\u0159ipadaj\u00edc\u00ed na 24.duben.<\/p>\n

\"ilustra\u010dn\u00ed<\/p>\n\n\n\n
\u00a0Sv\u011btov\u00fd den meningitidy <\/span><\/strong><\/p>\n

Sv\u011btov\u00fd den meningitidy si letos p\u0159ipom\u00edn\u00e1me u\u017e po \u010dtrn\u00e1ct\u00e9. Poprv\u00e9 byl mezin\u00e1rodn\u00ed Konfederac\u00ed organi-zac\u00ed pro meningitidu vyhl\u00e1\u0161en v roce 2008 a dnes je 24. duben v\u00fdznamn\u00fdm dnem zdravotn\u00ed osv\u011bty a prevence v des\u00edtk\u00e1ch zem\u00ed sv\u011bta. C\u00edlem Sv\u011btov\u00e9ho dne meningitidy je \u0161\u00ed\u0159it pov\u011bdom\u00ed o z\u00e1va\u017en\u00e9m onemocn\u011bn\u00ed a podpo\u0159it v\u00fdznam o\u010dkov\u00e1n\u00ed. Sv\u011btov\u00fd den meningitidy term\u00ednov\u011b spad\u00e1 do Sv\u011btov\u00e9ho t\u00fddne o\u010dkov\u00e1n\u00ed pod z\u00e1\u0161titou Sv\u011btov\u00e9 zdravotnick\u00e9 organizace. Ten se kon\u00e1 ka\u017edoro\u010dn\u011b v dubnu s c\u00edlem zv\u00fd\u0161it obecn\u00e9 pov\u011bdom\u00ed o v\u00fdznamu o\u010dkov\u00e1n\u00ed pro zdrav\u00ed a \u017eivotn\u00ed pohodu cel\u00e9 populace.<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Letos by mohlo b\u00fdt nao\u010dkov\u00e1no a\u017e 70 procent kojenc\u016f<\/strong><\/p>\n

Je d\u016fle\u017eit\u00e9, \u017ee hlavn\u00edm motivem o\u010dkov\u00e1n\u00ed je vedle finan\u010dn\u00ed dostupnosti tak\u00e9 obava ze z\u00e1va\u017en\u00e9ho onemocn\u011bn\u00ed, kter\u00e9 je zn\u00e1m\u00e9 sv\u00fdm velmi rychl\u00fdm pr\u016fb\u011bhem a v n\u011bkter\u00fdch p\u0159\u00edpadech m\u016f\u017ee k \u00famrt\u00ed nemocn\u00e9ho doj\u00edt ji\u017e b\u011bhem 24-48 hodin. Podle dosavadn\u00edho z\u00e1jmu a zvy\u0161uj\u00edc\u00ed se informovanosti pediat\u0159i usuzuj\u00ed, \u017ee letos vakc\u00ednu aplikuj\u00ed zhruba 67 % v\u0161ech d\u011bt\u00ed ve v\u011bku 2-6 m\u011bs\u00edc\u016f.<\/p>\n

Tento zvy\u0161uj\u00edc\u00ed se z\u00e1jem o o\u010dkov\u00e1n\u00ed je velmi \u017e\u00e1douc\u00ed, proto\u017ee meningokokov\u00e1 onemocn\u011bn\u00ed skupiny B podle statistik N\u00e1rodn\u00ed referen\u010dn\u00ed laborato\u0159e pro meningokokov\u00e9 n\u00e1kazy St\u00e1tn\u00edho zdravotn\u00edho \u00fastavu nej\u010dast\u011bji ohro\u017euj\u00ed pr\u00e1v\u011b nejmlad\u0161\u00ed d\u011bti. Invazivn\u00ed meningokokov\u00e9 onemocn\u011bn\u00ed nen\u00ed \u010dast\u00e9, ale o to v\u00edce je zr\u00e1dn\u00e9 a z\u00e1va\u017en\u00e9 a i p\u0159es vysp\u011blost zdravotn\u00ed p\u00e9\u010de se smrtnost na toto onemocn\u011bni pohybuje kolem 10 %.<\/p>\n

Vakc\u00edna Bexsero je registrovan\u00fd l\u00e9\u010div\u00fd p\u0159\u00edpravek v\u00e1zan\u00fd na l\u00e9ka\u0159sk\u00fd p\u0159edpis. O\u010dkov\u00e1n\u00ed prov\u00e1d\u00ed l\u00e9ka\u0159, vakc\u00edna se aplikuje do svalu formou injekce (obvykle do stehna nebo horn\u00ed \u010d\u00e1sti pa\u017ee). P\u0159ed pou\u017eit\u00edm si pe\u010dliv\u011b prostudujte p\u0159\u00edbalovou informaci dostupnou t\u00e9\u017e na\u00a0<\/strong>www.gskkompendium.cz<\/a>.<\/strong> P\u0159\u00edpadn\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky, pros\u00edm, nahlaste na\u00a0cz.safety@gsk.com<\/a>. O\u010dkov\u00e1n\u00ed nemus\u00ed chr\u00e1nit 100 % o\u010dkovan\u00fdch.<\/p>\n

Reference:<\/em><\/strong><\/p>\n

\u00a0<\/em><\/strong>1., 4., 5. IQVIA, V\u00fdsledky marketingov\u00e9ho pr\u016fzkumu pro spole\u010dnost GSK, realizov\u00e1no v\u00a0lednu a \u00fanoru 2021 na vzorku 98 l\u00e9ka\u0159\u016f.\u00a0 <\/em><\/p>\n

    \n
  1. Confederation of Meningitis Organisations, https:\/\/www.comomeningitis.org\/<\/a> <\/em><\/li>\n
  2. IQVIA, V\u00fdsledky marketingov\u00e9ho pr\u016fzkumu pro spole\u010dnost GSK, realizov\u00e1no v lednu a \u00fanoru 2021 na vzorku 201 matek s d\u011btmi ve v\u011bku od 2 do 6 m\u011bs\u00edc\u016f.<\/em><\/li>\n<\/ol>\n
    ZDEN\u011aK VESECK\u00dd<\/em><\/div>\n
    <\/div>\n","protected":false},"excerpt":{"rendered":"

    Views: 53Zhruba 2,5kr\u00e1t se za posledn\u00ed rok zv\u00fd\u0161ila proo\u010dkovanost nejmen\u0161\u00edch d\u011bt\u00ed proti onemocn\u011bn\u00edm zp\u016fsoben\u00fdmi meningokoky skupiny B. Za n\u00e1r\u016fstem z\u00e1jmu stoj\u00ed mimo jin\u00e9 i pln\u00e1 \u00fahrada vakc\u00edny, kter\u00e1 plat\u00ed p\u0159i zah\u00e1jen\u00ed o\u010dkov\u00e1n\u00ed do konce 6. m\u011bs\u00edce v\u011bku d\u00edt\u011bte. Podle odhadu l\u00e9ka\u0159\u016f by se letos d\u00edky tomu mohla proo\u010dkovanost kojenc\u016f dostat t\u00e9m\u011b\u0159 k 70 procent\u016fm.<\/p>\n","protected":false},"author":5,"featured_media":14108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,22],"tags":[],"class_list":["post-14101","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-rodina-a-drobotina","category-ranni-kavy"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t